Zai Lab Limited (HKG: 9688)
Hong Kong
· Delayed Price · Currency is HKD
20.90
+0.40 (1.95%)
Jan 28, 2025, 12:08 PM HKT
Zai Lab Employees
Zai Lab had 2,175 employees as of December 31, 2023. The number of employees increased by 139 or 6.83% compared to the previous year.
Employees
2,175
Change (1Y)
139
Growth (1Y)
6.83%
Revenue / Employee
1.27M HKD
Profits / Employee
-967.51K HKD
Market Cap
23.63B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
BeiGene | 10,600 |
Hansoh Pharmaceutical Group Company | 9,123 |
JD Health International | 3,118 |
WuXi Biologics | 12,740 |
Sinopharm Group | 115,959 |
Alibaba Health Information Technology | 1,435 |
Akeso | 2,778 |
Innovent Biologics | 4,872 |
Zai Lab News
- 2 days ago - Zai Lab to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Recent Corporate Updates on February 27, 2025 - Business Wire
- 7 days ago - Zai Lab Receives Orphan Drug Designation from the U.S. FDA for ZL-1310 (DLL3 ADC) for the Treatment of Small Cell Lung Cancer (SCLC) - Business Wire
- 13 days ago - Chinese regulators accept Zai Lab application for KarXT - Seeking Alpha
- 13 days ago - Zai Lab Ltd (ZLAB) Announces NDA Acceptance for KarXT in China - GuruFocus
- 13 days ago - Zai Lab Announces Acceptance of New Drug Application for KarXT for the Treatment of Schizophrenia - Business Wire
- 15 days ago - Zai Lab to seek China approval for cervical cancer therapy after positive trial data - Seeking Alpha
- 15 days ago - Zai Lab Announces Positive Topline Results for TIVDAK in the China Subpopulation of the Global Phase 3 innovaTV 301 Trial in Patients with Recurrent or Metastatic Cervical Cancer - Business Wire
- 20 days ago - Zai Lab Ltd (ZLAB) Partners with Vertex Pharmaceuticals for Povetacicept Development in Asia - GuruFocus